CRF receptor antagonists and methods relating thereto
申请人:Bristol-Myers Squibb Company
公开号:US06352990B1
公开(公告)日:2002-03-05
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.